Hygieia Pharmaceuticals
Latest round
- Series A
Last raised
- Sep 2024
Total raised
- Undisclosed
Investors
- 2
About Hygieia Pharmaceuticals
Founded in 2021 and based in Shanghai, China, Hygieia Pharmaceuticals is a biopharmaceutical company that focuses on the construction of siRNA delivery technology platform. The company's main products include MVIP delivery platform, DDP delivery platform and NSDP delivery platform. DDP is a second-generation siRNAs delivery technology platform developed by Hejia for liver diseases. The company is also developing drugs to treat liver disease, cardiovascular and cerebrovascular and metabolic diseases. The company’s revenue is generated by providing siRNA delivery technology platform and coupled delivery of siRNA small nucleic acid drugs.
Who invested in Hygieia Pharmaceuticals
2 investors across 1 round
See all investors in Hygieia Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 3, 2024
Amount
Undisclosed
Investors
Questions about Hygieia Pharmaceuticals
Who invested in Hygieia Pharmaceuticals?
Hygieia Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hygieia Pharmaceuticals raised?
Hygieia Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hygieia Pharmaceuticals last raise money?
Hygieia Pharmaceuticals's most recent round on record is a Series A, in Sep 2024.
What does Hygieia Pharmaceuticals do?
Founded in 2021 and based in Shanghai, China, Hygieia Pharmaceuticals is a biopharmaceutical company that focuses on the construction of siRNA delivery technology platform.
Where is Hygieia Pharmaceuticals headquartered?
Hygieia Pharmaceuticals is headquartered in Shanghai, China.
Which VCs invest in companies like Hygieia Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hygieia Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hygieia Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.